The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of OPTIMOX-aflibercept as first-line therapy on time to health-related quality of life deterioration in patients with unresectable metastatic colorectal cancer: results of the GERCOR VELVET phase II single arm study.
 
Julie Henriques
No Relationships to Disclose
 
Amelie Anota
No Relationships to Disclose
 
Benoist Chibaudel
Honoraria - Sanofi
Consulting or Advisory Role - Lilly; Sanofi
Travel, Accommodations, Expenses - Amgen; Merck; Roche; Sanofi
 
Jean-Baptiste Bachet
No Relationships to Disclose
 
Jean Baptiste Bachet
Employment - Merck (I); MSD (I)
Honoraria - Bayer; Sanofi
Consulting or Advisory Role - Amgen; Celgene; Lilly; Merck Serono; Roche
Travel, Accommodations, Expenses - Celgene; Merck Serono
 
Thierry André
Honoraria - Amgen; Baxter; Bayer; Bristol-Myers Squibb; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; MSD; Roche
 
Dominique Auby
No Relationships to Disclose
 
Jérôme Desramé
Expert Testimony - Roche
Travel, Accommodations, Expenses - Hospira
 
Nabil Baba Hamed
No Relationships to Disclose
 
Cedric Lecaille
No Relationships to Disclose
 
Christophe Louvet
Consulting or Advisory Role - Celgene; Roche; Sanofi
 
Christophe Tournigand
Consulting or Advisory Role - Sanofi
 
Valerie Lebrun-Ly
No Relationships to Disclose
 
Jérôme Dauba
No Relationships to Disclose
 
Marie-Line Garcia
No Relationships to Disclose
 
Olivier Dubreuil
No Relationships to Disclose
 
Malika Attia
No Relationships to Disclose
 
Aimery De Gramont
Consulting or Advisory Role - Roche; Sanofi
 
Franck Bonnetain
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Eisai; IntegraGen; invectys; Merck Serono; NESTLE; Novartis; Roche
Research Funding - Roche (Inst)